Proteome Sciences plc (LON:PRM – Get Free Report)’s share price traded down 14.1% on Monday . The stock traded as low as GBX 2.33 ($0.03) and last traded at GBX 2.36 ($0.03). 478 shares traded hands during trading, a decline of 100% from the average session volume of 157,244 shares. The stock had previously closed at GBX 2.75 ($0.03).
Proteome Sciences Stock Performance
The company has a market cap of £6.97 million, a PE ratio of -236.10 and a beta of 0.07. The business’s 50-day moving average is GBX 2.80 and its 200 day moving average is GBX 3.30.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Stories
- Five stocks we like better than Proteome Sciences
- What is the FTSE 100 index?
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Discover the 3 Best Performing Stocks That Went Public in 2024
- Best Stocks Under $10.00
- 3 Strategic ETFs for Bearish Investors Post-Election
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
